Skip to main content

Table 2 Outcomes

From: Intraoperative use of extracorporeal CO2 removal (ECCO2R) and emergency ECMO requirement in patients undergoing lung transplant: a case-matched cohort retrospective study

 

Standard treatment plus ECCO2R (N = 15)

Standard treatment (N = 23)

p-value

Odds ratio (95% CI)

Patients undergoing ECMO, n (%)

3 (20%)

17 (73.9%)

0.004

11.3 (2.36–54.5)

Mortality, n (%)

3 (20%)

9 (39.1%)

0.08

2.57 (0.56–11.7)

ECMO pts mortality, n/N (%)

2/3 (66.7 %)

9/17 (52.9%)

0.1

0.56 (0.04–7.44)

 

Standard treatment plus ECCO2R (N = 12)

Standard treatment (N = 14)

p-value

 

Mechanical ventilation days (day±sd)

3.8±4.2

3.7±2.8

0.33

 

ICU length of stay (day±sd)

16.3±15.5

20.6±16.5

0.54

 
 

Standard treatment plus ECCO2R (N = 15)

Standard treatment (N = 23)

p-value

Odds ratio (95% CI)

Tubes damages, n (%)

2 (13.3%)

0 (0%)

0.174

8.7 (0.39–195.01)

Surgical revision, n/N (%) (ECMO bleeding)

1/3 (33.3%)

2/17 (11.77%)

0.36

0.75 (0.22–62.77)

  1. In the upper side of the box, the rate of ECMO treatment in the standard treatment and standard treatment plus ECCO2R groups; in the middle side of the box, the mechanical ventilation days and postoperative ICU length of stay in the 2 groups (patients who had ECMO treatment were excluded); in the lower side of the box, the complications occurred in the 2 groups